- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
58
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
58 companies
Senores Pharmaceuticals
Market Cap: ₹23.8b
Develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally.
SENORES
₹517.05
7D
-5.9%
1Y
n/a
ECO Animal Health Group
Market Cap: UK£44.0m
Develops, registers, and markets pharmaceutical products for animals worldwide.
EAH
UK£0.65
7D
21.5%
1Y
-39.5%
Hypera
Market Cap: R$15.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$24.03
7D
20.3%
1Y
-15.8%
Medical Developments International
Market Cap: AU$51.3m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.46
7D
1.1%
1Y
-15.7%
Veracyte
Market Cap: US$2.5b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$32.23
7D
3.5%
1Y
66.9%
Xiamen Amoytop Biotech
Market Cap: CN¥30.4b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥74.76
7D
-1.3%
1Y
21.9%
BeiGene
Market Cap: US$27.7b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$244.90
7D
6.0%
1Y
59.5%
Sotera Health
Market Cap: US$3.2b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$11.16
7D
6.4%
1Y
-2.1%
MedinCell
Market Cap: €494.9m
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€14.97
7D
6.1%
1Y
18.2%
Genetic Signatures
Market Cap: AU$99.9m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.44
7D
7.3%
1Y
-35.8%
Yuhan
Market Cap: ₩8.6t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩115,000.00
7D
-0.3%
1Y
62.0%
Galderma Group
Market Cap: CHF 22.1b
Operates as a dermatology company worldwide.
GALD
CHF 93.25
7D
18.7%
1Y
39.6%
Tonghua Dongbao Pharmaceutical
Market Cap: CN¥14.5b
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
600867
CN¥7.52
7D
3.4%
1Y
-29.0%
ALTEOGEN
Market Cap: ₩19.7t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩369,000.00
7D
-6.1%
1Y
112.4%
BICO Group
Market Cap: SEK 2.7b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 38.74
7D
8.0%
1Y
-15.0%
Suzhou Zelgen BiopharmaceuticalsLtd
Market Cap: CN¥26.7b
Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
688266
CN¥100.78
7D
0.8%
1Y
88.7%
Shanghai OPM Biosciences
Market Cap: CN¥4.6b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥40.72
7D
-0.2%
1Y
22.1%
AcrobiosystemsLtd
Market Cap: CN¥5.6b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥47.08
7D
9.1%
1Y
25.4%
Formycon
Market Cap: €407.0m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€23.05
7D
0.4%
1Y
-42.3%
BioLife Solutions
Market Cap: US$1.2b
Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.
BLFS
US$24.96
7D
13.9%
1Y
42.4%
Zhejiang Wolwo Bio-Pharmaceutical
Market Cap: CN¥10.4b
A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.
300357
CN¥19.81
7D
-0.6%
1Y
-16.4%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥8.2b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥15.25
7D
6.2%
1Y
41.3%
Innovent Biologics
Market Cap: HK$89.6b
A biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People’s Republic of China.
1801
HK$54.35
7D
15.0%
1Y
38.8%
Genscript Biotech
Market Cap: HK$24.0b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$11.06
7D
6.3%
1Y
0.4%
Beijing Luzhu Biotechnology
Market Cap: HK$4.9b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in China.
2480
HK$24.50
7D
-1.0%
1Y
-13.4%
Betta Pharmaceuticals
Market Cap: CN¥21.4b
Researches and develops, manufactures, and markets medicines for the treatment of cancer in China.
300558
CN¥51.20
7D
3.4%
1Y
26.3%
SK Biopharmaceuticals
Market Cap: ₩8.1t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩103,200.00
7D
-1.5%
1Y
23.6%
Solara Active Pharma Sciences
Market Cap: ₹24.5b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹508.85
7D
-2.8%
1Y
-6.2%
Almirall
Market Cap: €2.1b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€9.66
7D
3.1%
1Y
12.7%
Vertex Pharmaceuticals
Market Cap: US$126.6b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$493.84
7D
1.0%
1Y
24.2%
Strides Pharma Science
Market Cap: ₹60.2b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.
STAR
₹653.45
7D
0.07%
1Y
-25.5%
ArcticZymes Technologies
Market Cap: NOK 858.0m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally.
AZT
NOK 16.80
7D
-1.2%
1Y
-35.4%
Zhejiang Tianyu Pharmaceutical
Market Cap: CN¥7.4b
Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.
300702
CN¥21.42
7D
8.7%
1Y
18.3%
Bruker
Market Cap: US$5.9b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$39.07
7D
7.7%
1Y
-51.7%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €178.7m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€7.30
7D
2.5%
1Y
-13.1%
Repligen
Market Cap: US$8.2b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$144.75
7D
11.3%
1Y
-13.1%